Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physical Training with Aspirin vs Clopidogrel in Stage II PAD
NCT00189618Phase 4Completed
- Sponsor
- Arteriogenesis Competence Network
- Start
- May 2005
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised trial of clopidogrel in Peripheral Arterial Disease (PAD) (2 arms), sponsored by Arteriogenesis Competence Network. Primary endpoint: Absolute claudication distance at 3 months. Started May 2005; status: completed.
02
Drugs
clopidogrel
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT00189618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00189618.